Photos

  • Brent Del Monte of BGR Government Affairs, giving the Legislative Update
  • Attendees in the amphitheater
  • The Quality Technical Group panel
  • Tara Gooen-Bizjak of FDA discusses Quality Metrics
  • Ian Tzeng of L.E.K. Consulting on End-User Trends & CDMO implications
  • Cell & Gene Therapy panel, including Advanced Therapeutics, Catalent Gene Therapy, and FDA/CBER
  • Jim Miller closes out day 1 with Parting Thoughts on the CDMO sector
  • Informal networking dinner at JALEO in Bethesda!
  • The PBOA Rat Pack
  • Jim Miller receiving the inaugural PBOA Founders’ Award from Catalent’s Cornell Stamoran
  • Don’t break it!
  • Alonza Cruse of FDA on FDA/EMA mutual recognition of inspections
  • Adam Sybowsky of MasterControl on bridging quality in a paperless environment
  • Boyd Spencer of McKinsey on AI and Big Data in Pharma Manufacturing
  • Sulay Sandy of McKinsey/QuantumBlack on AI and Big Data in Pharma Manufacturing
  • Sue Schniepp of RCA Inc. on Data Integrity & CDMOs
  • Dave Windley of Jeffries LLC on M&A Trends in the pharma services sector
  • Eric Marshall of PDSA/Leavitt Partners on DSCSA issues and next steps
  • Bob DiScipio of Skyland Analytics on business and legal risks in outsourcing
  • Teresa Sankner of Novartis closed out the conference with “Talent & Diversity: Gaining a Competitive Advantage to Attract and Retain Top Talent”